4-AcO-DALT

4-Acetyloxy-N,N-diallyltryptamine (or 4-AcO-DALT) is a tryptamine derivative. It has been sold as a designer drug, but little other information is available. It was first officially identified in seized drug samples in 2012.[1]

4-AcO-DALT
Clinical data
Other names4-Acetyloxy-N,N-diallyltryptamine; 1H-Indol-4-ol, 3-(2-(di-2-propen-1-ylamino)ethyl)-, 4-acetate; 3-(2-(Di(prop-2-en-1-yl)amino)ethyl)-1H-indol-4-yl acetate; Dalcetin
Identifiers
IUPAC name
  • [3-[2-[bis(prop-2-enyl)amino]ethyl]-1H-indol-4-yl] acetate
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC18H22N2O2
Molar mass298.386 g·mol−1
3D model (JSmol)
SMILES
  • CC(=O)Oc1cccc2c1c(c[nH]2)CCN(CC=C)CC=C
InChI
  • InChI=1S/C18H22N2O2/c1-4-10-20(11-5-2)12-9-15-13-19-16-7-6-8-17(18(15)16)22-14(3)21/h4-8,13,19H,1-2,9-12H2,3H3
  • Key:WRHFDIBXZYYCHO-UHFFFAOYSA-N

See also

References
  1. EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.